Portside Wealth Group, LLC

Position in NVO — Novo Nordisk A S

CIK 1978608 Provo, UT

Position in NVO

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$3,655,808

+$926,276 QoQ

Shares Held

76,258

+2.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#261

of 1,348 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Portside Wealth Group, LLC holds $35,072,554 across 13 Drug Manufacturers - General names. NVO ranks #4 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	28,497	$7,237,382
2	LLY	ELI LILLY & Co	5,720	$6,860,739
3	ABBV	AbbVie Inc.	17,712	$4,457,047
4	NVO	Novo Nordisk A S This page	76,258	$3,655,808
5	MRK	Merck & Co., Inc.	21,032	$2,702,612
6	PFE	Pfizer Inc	89,045	$2,144,203
7	GILD	Gilead Sciences, Inc.	15,449	$1,951,826
8	NVS	Novartis AG	12,409	$1,944,738

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,655,808	76,258	+2.7%	Shares	Other	2026-07-14
2026-03-31	$2,729,532	74,273	+60.6%	Shares	Other	2026-05-12
2025-12-31	$2,352,538	46,237	-6.4%	Shares	Sole	2026-01-21
2025-09-30	$2,742,037	49,415	+18.4%	Shares	Sole	2025-11-05
2025-06-30	$2,880,755	41,738	-6.3%	Shares	Sole	2025-08-11
2025-03-31	$3,093,690	44,552	-17.0%	Shares	Other	2025-04-14
2024-12-31	$4,617,983	53,685	-9.0%	Shares	Other	2025-04-14
2024-09-30	$7,026,915	59,015	+3.9%	Shares	Sole	2024-10-31
2024-06-30	$8,109,773	56,815	-0.6%	Shares	Other	2024-07-18
2024-03-31	$7,338,188	57,151	-3.7%	Shares	Other	2024-04-17
2023-12-31	$6,136,757	59,321	-5.6%	Shares	Other	2024-01-16
2023-09-30	$5,714,214	62,835	+279.5%	Shares	Other	2023-10-27
2023-06-30	$2,679,419	16,557	—	Shares	Other	2023-09-01
No filing history on record for this holder in this stock.